Table 2.
Serotype | Country | No. | Diagnostics | Endocrine Disturbances | Time to Detection | Duration | Outcome | Ref |
---|---|---|---|---|---|---|---|---|
Puumala | Finland | 1 | NE-IFAT titre | Panhypopituarism | 5 years | NR | Survived | Forslund et al., 1992 [38] |
Puumala | Sweden | 1 | Specific Puumala IgM and IgG | Panhypopituitarism | 6 months | NR | Survived | Settergen et al., 1992 [40] |
NR | Korea | 1 | Serologic antibody testing | Panhypopituitarism | Day 20 a | NR | Survived | Suh et al., 1994 [37] |
Puumala | Finland | 4 | NR | NR | - | - | Deceased | Valtonen et al., 1995 b [9] |
NR | Korea | 1 | NR | Panhypopituitarism | 13 years | NR | Survived | Kim et al., 2001 [41] |
Puumala b
Puumala Puumala |
Finland Finland Finland |
1 1 1 |
Serologic antibody testing Serologic antibody testing Serologic antibody testing |
NR Panhypopituitarism Panhypopituitarism |
- 5 months Day 7 a |
- NR NR |
Deceased Survived Survived |
Hautala et al., 2002 [44] |
NR
Puumala Puumala |
Serbia Serbia Serbia |
1 1 1 |
Serologic antibody testing Serologic antibody testing Serologic antibody testing |
Panhypopituitarism Panhypopituitarism ACTH, FSH, LH and GH |
1.5 years 2 years 2 years |
NR NR NR |
Survived Survived Survived |
Pekic et al., 2005 [42] |
NR
NR NR NR |
Serbia Serbia Serbia Serbia |
3 2 1 5 |
Indirect immunofluorescent assay Indirect immunofluorescent assay Indirect immunofluorescent assay Indirect immunofluorescent assay |
GH FSH, LH ACTH ≥4 axes |
>6 months >6 months >6 months 0.5–11 yrs |
NR NR NR NR |
Survived Survived Survived Survived |
Stojanovic et al., 2008 [42] |
Puumala | Austria | 1 | Specific Puumala IgM | Panhypopituitarism | Acute a | 5 months | Survived | Jost et al., 2009 [39] |
Dobrova | Turkey | 1 | Serologic antibody testing | Panhypopituitarism | Day 19 a | 16 months | Survived | Sariguzel et al., 2010 [36] |
Puumala | Finland | 1 | Specific Puumala IgM and IgG | TSH, FSH, LH, ADH | 6 months | Ongoing | Survived | Tarvainen et al., 2016 [17] |
a Hormonal disturbances detected during acute infection; b Post-mortem study revealing pituitary hemorrhage. NR: not reported.